SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about press release

03 Apr 2025 Evaluate
Gland Pharma has informed that it enclosed Press Release - Gland Pharma receives approval from the United States Food and Drug Administration (US FDA) for Acetaminophen Injection, 10 mg/mL (500mg/50mL and 1000mg/100mL) Bags.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1747.25 11.25 (0.65%)
17-Apr-2026 09:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1686.80
Dr. Reddys Lab 1219.00
Cipla 1233.00
Zydus Lifesciences 939.65
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×